Experiments conducted on melanoma cell cultures have shown that CAFs release CXC motif chemokine 5 (CXCL5), which, in turn, induces PI3K/ protein kinase B (AKT)-dependent PDL-1 expression and resistance to immunotherapy in melanoma cells (Figure 3E) [102]. This evidence concerns the gene CXCL5 and melanoma.